[vc_row top_margin=”none” el_position=”first”] [vc_column top_margin=”none”] [mc_carousel id=”carousel” carousel_images=”2773,2772,2771,2770″ features_images_loop=”1″ lightbox_icon_color=”blue_light” autoplay=”0″ pause_on_hover=”1″ scroll=”1″ effect=”scroll” easing=”swing” duration=”500″ top_margin=”page_margin_top_section” el_position=”first last”] [/vc_column] [/vc_row] [vc_row top_margin=”none” el_position=”last”] [vc_column top_margin=”none”] [vc_column_text el_position=”first last”]
New Stomach Cancer Subtypes Uncovered With Proteomics
March, 2018
https://www.genomeweb.com/proteomics-protein-research/new-stomach-cancer-subtypes-uncovered-proteomics
Adding Targeted Therapy to Chemotherapy Improves Survival and Quality of Life for People with Metastatic Stomach Cancer Gastrointestinal Cancers Symposium
January 14, 2014
http://www.cancer.net/research-and-advocacy/research-summaries/adding-targeted-therapy-chemotherapy-improves-survival-and-quality-life-people-metastatic-stomach
FDA Approves Ramucirumab for Stomach Cancer
ASCO
May, 2014
http://www.ascopost.com/issues/may-15,-2014/fda-approves-ramucirumab-for-stomach-cancer.aspx
[/vc_column_text] [/vc_column] [/vc_row]